Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex.
Journal Information
Full Title: Orphanet J Rare Dis
Abbreviation: Orphanet J Rare Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateNot applicable to this manuscript. Consent for publicationNot applicable to this manuscript. Competing interestsThis study was funded by GW Global Services (International) Ltd. Editorial and medical writing services were provided by Costello Medical. S. Amin, has provided consultancy and speaker services, and has participated in events and studies, for GW Global Services (International) Ltd; Medtronic Limited, Boston Scientific, Novartis, PTC therapeutics and Desitin; I. Newell, employee of Costello Medical; B. Ruban-Fell, employee of Costello Medical; J. Evans, employee of Costello Medical; K. Vyas, employee of GW Global Services (International) Ltd; C. Nortvedt, employee of GW Global Services (International) Ltd; R.F.M. Chin, has provided consultancy and speaker services, and has participated in events and studies, for GW Global Services (International) Ltd, Eisai, Zogenix, Neopharm Group and The Rize Medical Cannabis and Life Sciences UCITS ETF. Competing interests This study was funded by GW Global Services (International) Ltd. Editorial and medical writing services were provided by Costello Medical. S. Amin, has provided consultancy and speaker services, and has participated in events and studies, for GW Global Services (International) Ltd; Medtronic Limited, Boston Scientific, Novartis, PTC therapeutics and Desitin; I. Newell, employee of Costello Medical; B. Ruban-Fell, employee of Costello Medical; J. Evans, employee of Costello Medical; K. Vyas, employee of GW Global Services (International) Ltd; C. Nortvedt, employee of GW Global Services (International) Ltd; R.F.M. Chin, has provided consultancy and speaker services, and has participated in events and studies, for GW Global Services (International) Ltd, Eisai, Zogenix, Neopharm Group and The Rize Medical Cannabis and Life Sciences UCITS ETF."
"Funding This study was sponsored by GW Global Services (International) Ltd. Support for third-party writing assistance for this article, provided by Eleanor Thurtle, MChem, Costello Medical, UK, was funded by GW Global Services (International) Ltd in accordance with Good Publication Practice (GPP3) guidelines (http://www.ismpp.org/gpp3)."
"Trial registration Not applicable."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025